Arkolith/Insider Trading/SNTI/Form 4

Lu Timothy K

CEO and Interim PFO and PAO, DirectorSenti Biosciences, Inc. (SNTI) · full profile →Form 4 · filed Mar 10, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 7, 2025Grant(A)642K—$0724K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 6, 2025Grant(A)1.9M—$01.9M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001854270-25-000013) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML